Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically

Breast Cancer Res Treat. 2018 Feb;167(3):817-818. doi: 10.1007/s10549-017-4535-7. Epub 2017 Oct 13.

Authors

Alessandra Ravaioli¹, Fabio Falcini^{1

2}, Lauro Bucchi³

Affiliations

¹ Romagna Cancer Registry, Romagna Cancer Institute (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS), Meldola, Forlì, Italy.
² Romagna Local Health Unit, Forlì, Italy.
³ Romagna Cancer Registry, Romagna Cancer Institute (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS), Meldola, Forlì, Italy. [email protected].

PMID: 29027616
DOI: 10.1007/s10549-017-4535-7

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal / therapeutic use
Breast Neoplasms / drug therapy
Breast Neoplasms / epidemiology
Breast Neoplasms / genetics*
Breast Neoplasms / pathology
Carcinoma, Ductal, Breast / drug therapy
Carcinoma, Ductal, Breast / epidemiology
Carcinoma, Ductal, Breast / genetics*
Carcinoma, Ductal, Breast / pathology
Carcinoma, Lobular / drug therapy
Carcinoma, Lobular / epidemiology
Carcinoma, Lobular / genetics*
Carcinoma, Lobular / pathology
Estrogen Receptor alpha / genetics
Female
Gene Expression Regulation, Neoplastic / genetics
Humans
Middle Aged
Netherlands / epidemiology
Receptors, Progesterone / genetics

Substances

Antineoplastic Agents, Hormonal
ESR1 protein, human
Estrogen Receptor alpha
Receptors, Progesterone